Virus-Like Particles of mRNA with Artificial Minimal Coat Proteins: Particle Formation, Stability, and Transfection Efficiency

被引:30
作者
Jekhmane, Shehrazade [1 ]
de Haas, Rob [1 ]
Filho, Omar Paulino da Silva [2 ,3 ]
van Asbeck, Alexander H. [2 ]
Favretto, Marco Emanuele [2 ,5 ]
Garcia, Armando Hernandez [4 ,6 ]
Brock, Roland [2 ]
de Vries, Renko [1 ]
机构
[1] Wageningen Univ, Phys Chem & Soft Matter, Stippeneng 4, NL-6708 WE Wageningen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands
[3] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil
[4] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA
[5] Univ Chester, Dept Biol Sci, Chester, Cheshire, England
[6] Univ Nacl Autonoma Mexico, Inst Chem, Dept Chem Biomacromol, Mexico City, DF, Mexico
关键词
virus-like particles; mRNA delivery; self-assembly; GENE DELIVERY; HALF-LIFE; IN-VIVO; PEPTIDES; PLATFORM; DRUG;
D O I
10.1089/nat.2016.0660
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA has enormous potential as a therapeutic, yet, the successful application depends on efficient delivery strategies. In this study, we demonstrate that a designed artificial viral coat protein, which self-assembles with DNA to form rod-shaped virus-like particles (VLPs), also encapsulates and protects mRNA encoding enhanced green fluorescent protein (EGFP) and luciferase, and yields cellular expression of these proteins. The artificial viral coat protein consists of an oligolysine (K-12) for binding to the oligonucleotide, a silk protein-like midblock S-10 = (GAGAGAGQ)(10) that self-assembles into stiff rods, and a long hydrophilic random coil block C that shields the nucleic acid cargo from its environment. With mRNA, the C-S-10-K-12 protein coassembles to form rod-shaped VLPs each encapsulating about one to five mRNA molecules. Inside the rod-shaped VLPs, the mRNAs are protected against degradation by RNAses, and VLPs also maintain their shape following incubation with serum. Despite the lack of cationic surface charge, the mRNA VLPs transfect cells with both EGFP and luciferase, although with a much lower efficiency than obtained by a lipoplex transfection reagent. The VLPs have a negligible toxicity and minimal hemolytic activity. Our results demonstrate that VLPs yield efficient packaging and shielding of mRNA and create the basis for implementation of additional virus-like functionalities to improve transfection and cell specificity, such as targeting functionalities.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 20 条
  • [1] The journey of a drug-carrier in the body: An anatomo-physiological perspective
    Bertrand, Nicolas
    Leroux, Jean-Christophe
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) : 152 - 163
  • [2] Chilkoti A., 2013, US Patent, Patent No. [2013/0143802 A1, 20130143802]
  • [3] Nanotechnological approaches for the delivery of macromolecules
    Crommelin, DJA
    Storm, G
    Jiskoot, W
    Stenekes, R
    Mastrobattista, E
    Hennink, WE
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) : 81 - 88
  • [4] Multifunctional poly(methacrylate) polyplex libraries: A platform for gene delivery inspired by nature
    Favretto, M. E.
    Krieg, A.
    Schubert, S.
    Schubert, U. S.
    Brock, R.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 209 : 1 - 11
  • [5] Cancer immunotherapy with mRNA-transfected dendritic cells
    Gilboa, E
    Vieweg, J
    [J]. IMMUNOLOGICAL REVIEWS, 2004, 199 (01) : 251 - 263
  • [6] Hernandez-Garcia A, 2014, NAT NANOTECHNOL, V9, P698, DOI [10.1038/NNANO.2014.169, 10.1038/nnano.2014.169]
  • [7] Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
    Jayaraman, Muthusamy
    Ansell, Steven M.
    Mui, Barbara L.
    Tam, Ying K.
    Chen, Jianxin
    Du, Xinyao
    Butler, David
    Eltepu, Laxman
    Matsuda, Shigeo
    Narayanannair, Jayaprakash K.
    Rajeev, Kallanthottathil G.
    Hafez, Ismail M.
    Akinc, Akin
    Maier, Martin A.
    Tracy, Mark A.
    Cullis, Pieter R.
    Madden, Thomas D.
    Manoharan, Muthiah
    Hope, Michael J.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (34) : 8529 - 8533
  • [8] Kallen Karl-Josef, 2014, Ther Adv Vaccines, V2, P10, DOI 10.1177/2051013613508729
  • [9] GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery
    Li, WJ
    Nicol, F
    Szoka, FC
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (07) : 967 - 985
  • [10] Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice
    Liu, Wenge
    Dreher, Matthew R.
    Furgeson, Darin Y.
    Peixoto, Katia V.
    Yuan, Hong
    Zalutsky, Michael R.
    Chilkoti, Ashutosh
    [J]. JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) : 170 - 178